BenefitsPRO: Employee Benefits News, Trends & Sales Tips

What can insurers learn from millennials' obsession with pet insurance?

By Stephen Crewdson

The likelihood of consumers purchasing insurance for valuables, pets and households varies based on age, education and location.

Read Story

Market Insights

Humira biosimilars are finally here: What brokers and TPAs need to know

Market Insights

ACA record enrollment: Too many patients, not enough doctors?

Recommended Just For You

Market Insights Stories

April 07, 2023

Patients are getting blindsided by 'facility fees,' and states are taking action

About half of all patients are getting hit with facility fees, which are billed for doctor visits at hospital-owned clinics, as three in four physicians are now employed by hospitals, health systems or other corporate entities.

Read

April 07, 2023

Xanax and Adderall's 'secret drug limits' due to opioid settlement with top 3 distributors

The limits stem from an opioid settlement with AmerisourceBergen, Cardinal Health and McKesson that flag and sometimes block controlled substances – and patients with anxiety and sleep disorder are caught in the crosshairs.

Read

April 07, 2023

'Loud layoffs' at tech companies are sending mixed messages to other employers

The recent high-profile layoffs at Apple, Google and Microsoft may make it seem like the labor market is in trouble, but six in 10 employers say they are not planning layoffs, according to a new report.

Read

April 06, 2023

HIPAA hypocrisy? 99% of hospital websites send patient data to third parties

Nearly every U.S. hospital shared data with third-party trackers in 2021 and "some significant portion of these are including protected health information," according to a new Health Affairs study.

Read

April 03, 2023

The new era of settlement agreements is unsettling: Giving up your first amendment rights

These latest agreements, and their unfair attempts to restrict a person's future free speech rights, are in a different category entirely.

Read

March 29, 2023

Biosimilars: Safe, effective treatment options that lower the cost of prescription drugs

Global sales of these lower-cost versions of patented and branded drugs topped $15 billion in 2020, while the market is set to double in size to more than $30 billion by 2025, according to a McKinsey report.

Read

March 23, 2023

Are disability benefits actually enough to live on?

Using 2022 data from the Social Security Administration, Atticus researchers found disability benefits are rarely enough to cover even half of someone's cost of living.

Read

‹ ‹ PREV 84 85 86 ... 209 › NEXT ›

Market Insights

Top Market Insights Stories

What can insurers learn from millennials' obsession with pet insurance?

Humira biosimilars are finally here: What brokers and TPAs need to know

ACA record enrollment: Too many patients, not enough doctors?

Recommended Just For You

Market Insights Stories

Patients are getting blindsided by 'facility fees,' and states are taking action

Xanax and Adderall's 'secret drug limits' due to opioid settlement with top 3 distributors

'Loud layoffs' at tech companies are sending mixed messages to other employers

HIPAA hypocrisy? 99% of hospital websites send patient data to third parties

The new era of settlement agreements is unsettling: Giving up your first amendment rights

Biosimilars: Safe, effective treatment options that lower the cost of prescription drugs

Are disability benefits actually enough to live on?